Search

Search Results

• MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

  Ibrahim C. Haznedaroglu

  e2014009

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.009

  3800

  PDF: 1428

  HTML: 9169

  Untitled: 255

  Untitled: 158

  Untitled: 148

  Untitled: 143

  Untitled: 162

  Untitled: 315

• A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β⁺-Thalassaemia Patient

  Marta Bortolotti, Gianluca Costamagna, Marta Mancarella, Delia Gagliardi, Silvia Lanfranconi, Alessia Marcon, Margherita Migone De Amicis, Nereo Bresolin, Stefania Corti, Giovanna Graziadei

  e2022019

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.019

  918

  PDF: 499

  HTML: 224

• PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

  matteo molica, elisabetta abruzzese, massimo breccia

  e2020062

  2020-09-12

  https://doi.org/10.4084/mjhid.2020.062

  3331

  PDF: 1488

  HTML: 534

• EVALUATION OF GLUTATHIONE-S-TRANSFERASE P1 POLYMORPHISM AND ITS RELATION TO BONE MINERAL DENSITY IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH BETA- THALASSEMIA MAJOR

  Seham Ragab

  e2016004

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.004

  3838

  PDF: 812

  HTML: 2411

  Figures: 149

• MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER

  Paola Ranalli, Stefano Baldoni, Daniela Bruno, Mauro Di Ianni

  e2024067

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.067

  1056

  PDF: 602

  Html: 136

• Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

  Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza

  e2017020

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.020

  2845

  PDF: 923

  HTML: 518

• Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

  Zhan Su, Feng Wang

  e2025063

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.063

  811

  PDF: 435

  HTML: 112

  Suppl. Files: 286

• Association of the SOD2 polymorphism (Val6Ala) and SOD activity with vaso-occlusive crisis and acute splenic sequestration in children with sickle cell anemia

  Isabela Cristina Cordeiro Farias, Taciana Furtado Mendonça-Belmont, Andreia Soares Silva, Kleyton Palmeira do Ó, Felipe Borba Ferreira, Fernanda Silva Medeiros, Luydson Richardson Silva Vasconcelos, Moacyr Jesus Barreto de Melo Rego, Marcos Andre Cavalcanti Bezerra, Aderson Silva Araujo, Patricia Muniz Mendes Freire Moura, Ana Claudia Mendonça Anjos, Betânia Lucena Domingues Hatzlhofer, Maria do Socorro Mendonça Cavalcanti

  e2018012

  2018-02-21

  https://doi.org/10.4084/mjhid.2018.012

  2898

  PDF: 908

  HTML: 386

• SICKLE CELL ANAEMIA AND MALARIA

  Lucio Luzzatto

  e2012065

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.065

  11032

  PDF: 6780

  HTML: 23777

  Figures Malaria and SCK: 179

• INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund

  e2009028

  2009-12-28

  1034

  PDF: 590

  HTML: 4261

• ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE

  Eleonora Boscaro

  e2024063

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.063

  891

  PDF: 871

  HTML: 94

• SURVIVAL PROBABILITY IN PATIENTS WITH SICKLE CELL ANEMIA USING THE COMPETITIVE RISK STATISTICAL MODEL

  Samir Ballas, Emilia Matos do Nascimento, PhD, Clarisse Lopes de Castro Lobo, MD, Basilio de Bragança Pereira, PhD

  e2019022

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.022

  1446

  PDF: 891

  HTML: 181

• Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

  Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori

  e2013029

  2013-04-15

  https://doi.org/10.4084/mjhid.2013.029

  1405

  PDF: 784

  HTML: 1207

• SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

  Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna

  e2021068

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.068

  1413

  PDF: 887

  HTML: 207

• THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE

  Samir Ballas

  e2020010

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.010

  3030

  PDF: 2872

  HTML: 1078

• AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

  Pasquale Niscola

  e2014020

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.020

  1594

  PDF: 857

  HTML: 2758

• TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment

  Alessandro Buonomo, Eleonora Nucera, Marianna Criscuolo

  e2022040

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.040

  1941

  PDF: 1445

  HTML: 255

• 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

  Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso

  e2011011

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.011

  1522

  PDF: 736

  HTML: 1095

• NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

  Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera

  e2020083

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.083

  1522

  PDF: 1126

  HTML: 181

• COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

  M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher

  e2009029

  2009-12-28

  1031

  PDF: 468

  HTML: 8133

• FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

  Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo

  e2024029

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.029

  892

  PDF: 1178

  HTML: 88

• AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

  Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Peter C. Huijgens

  e2013018

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.018

  2239

  PDF: 779

  HTML: 3261

• Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)

  Salam Alkindi, Dr. , Dr.

  e2021059

  2021-09-01

  https://doi.org/10.4084/MJHID.2021.059

  1992

  PDF: 450

  HTML: 115

• Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

  Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella

  e2025066

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.066

  825

  PDF: 557

  Html: 95

• THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

  Pau Montesinos, Miguel A Sanz

  e2011059

  2011-12-04

  https://doi.org/10.4084/mjhid.2011.059

  2926

  PDF: 1467

  HTML: 2387

• The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases

  Laila Al Yazidi

  e2020074

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.074

  759

  PDF: 658

  HTML: 290

• SICKLE CELL DISEASE AND PREGNANCY

  Dipty Jain, Pooja Lodha, Roshan Colah, Prachi Atmapoojya, Prachi Atmapoojya

  e2019040

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.040

  5770

  PDF: 3565

  HTML: 414

• IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

  Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica

  e2021062

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.062

  1127

  PDF: 436

  HTML: 139

• Major Artery Occlusion: a Rare Complication of Sickle Cell Disease

  Adnan Agha

  e2010007

  https://doi.org/10.4084/mjhid.2010.007

  1295

  PDF: 1008

  HTML: 4593

• HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease

  Abdullah Al-Jefri, Fatema Al-Hashem, Khawar, Amal Al-Seraihy, Ali Al-Ahmari, Ibrahim Ghemlas, Awatif AlAnazi, Hawazen Al-Saedi, Saadiya Khan, Abdulrahman Al-Musa, Mahasen Saleh, Mouhab Ayas

  e2025030

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.030

  1054

  PDF: 851

  HTML: 320

• THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

  Ignazio Majolino

  e2017031

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.031

  2176

  PDF: 961

  HTML: 2065

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3547

  PDF: 884

  HTML: 4422

• A MULTICENTRE ICET-A STUDY OF CONFIRMED SARS-COV-2 INFECTION IN PATIENTS WITH HEMOGLOBINOPATHIES: PRELIMINARY DATA FROM 10 COUNTRIES

  Vincenzo De Sanctis

  e2020046

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.046

  2661

  PDF: 1532

  HTML: 286

• Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia

  Monique A Hartley-Brown, Lubomir Sokol, Gisela L Caceres, Mohammed A Hussein, Alan List, Javier Pinilla-Ibarz

  e2010002

  2010-02-23

  https://doi.org/10.4084/mjhid.2010.002

  962

  PDF: 528

  HTML: 376

• CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

  Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda

  e2019067

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.067

  2766

  PDF: 1777

  HTML: 725

• SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

  Zohreh Rahimi, Abbas Parsian

  e2011024

  2011-05-23

  https://doi.org/10.4084/mjhid.2011.024

  2152

  PDF: 825

  HTML: 2057

• A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients

  Kanchan Mishra, Avani Shah, Krima Patel, Kanjaksha Ghosh, Sumit Bharadva

  e2020038

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.038

  1247

  PDF: 739

  HTML: 464

• INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

  Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene

  e2018029

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.029

  2694

  PDF: 969

  HTML: 289

• PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas

  Manal Alsaif, Joan Robinson, Moshtag Abdulbaqi, Mustafa Aghbari, Khalid Al Noaim, Muneera Alabdulqader

  e2021002

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.002

  1399

  PDF: 530

  HTML: 195

• Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

  Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

  e2016016

  2016-02-20

  https://doi.org/10.4084/mjhid.2016.016

  2842

  PDF: 661

  HTML: 1918

  figure 1: 145

  figure 2: 159

• PREVALENCE AND FACTORS ASSOCIATED WITH HUMAN PARVOVIRUS B19 INFECTION IN SICKLE CELL PATIENTS HOSPITALIZED IN TANZANIA

  Florence Urio, Humphrey George, Furahini Tluway, Thomas B Nyambo, Bruno P Mmbando, Julie Makani

  e2019054

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.054

  1591

  PDF: 1177

  HTML: 199

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  2857

  PDF: 977

  HTML: 4559

• END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life

  Dr. Sophia Delicou, Dr Katerina Xydaki, Dr Maria Moraki, Dr Theodoros Aforozis

  e2026015

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.015

  873

  PDF: 510

  Html: 141

• CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

  adel abd elhaleim hagag, Ghada Elmashad, Aml Ezzat Abd El-Lateef

  e2014044

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.044

  1715

  PDF: 883

  HTML: 2219

• Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

  Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso

  e2022058

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.058

  1542

  PDF: 717

  HTML: 222